NovaBridge Biosciences (NBP)
NovaBridge Biosciences Market Cap: 471.44M for Dec. 10, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| GT Biopharma, Inc. | 7.153M |
| Plus Therapeutics, Inc. | 92.38M |
| Iovance Biotherapeutics, Inc. | 897.15M |
| 4D Molecular Therapeutics, Inc. | 618.77M |
| Aura Biosciences, Inc. | 410.87M |
Market Cap Related Metrics
| Price | 4.09 |